Annual report
6894.TEDINET S100W2ND
Period2024-04-01 → 2025-03-31
Filed2025-06-23
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥2.6bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥2.4bn | 2022-04-01 → 2023-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.4bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.1bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥336m | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | ¥358m | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | ¥354m | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥387m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥333m | 2022-04-01 → 2023-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥352m | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥192m | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥340m | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥426m | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥356m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥327m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥243m | 2022-04-01 → 2023-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥340m | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥157m | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥356m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | ¥327m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥5.0bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥5.2bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥4.5bn | at 2023-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥4.6bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥4.0bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.2bn | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥1.5bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥3.9bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.7bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.4bn | at 2023-03-31d | Cons. | Net assets |
| Net assets / equity | ¥3.3bn | at 2022-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥3.0bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.0bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.3bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.9bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.3bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.9bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.2bn | at 2022-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.7bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥153m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥399m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥105m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥659m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥646m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥375m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥89m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥24m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥66m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥28m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥159m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥146m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥226m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥72m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥55m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥260.19 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥238.99 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥177.53 | 2022-04-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥248.75 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥114.4 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥2,823.85 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,685.76 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,497.84 | at 2023-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,392.34 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,188.43 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 76.8% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.9% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.6% | at 2023-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.4% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.9% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 9.4% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.2% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.3% | 2022-04-01 → 2023-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.9% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.3% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 124 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 128 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 134 | at 2023-03-31d | Cons. | Number of employees |
| Employees | 134 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 136 | at 2021-03-31d | Cons. | Number of employees |
| Revenue | ¥2.5bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥2.6bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥2.4bn | 2022-04-01 → 2023-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.4bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.1bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥342m | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | ¥351m | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | ¥357m | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥377m | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥328m | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥342m | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥190m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥343m | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥416m | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | ¥360m | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥319m | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥241m | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥331m | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥154m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥5.0bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥5.1bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥4.5bn | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥4.6bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥4.0bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.1bn | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥1.5bn | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥3.8bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥3.6bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥3.4bn | at 2023-03-31d | Standalone | Net assets |
| Net assets / equity | ¥3.3bn | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥3.0bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.9bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥2.2bn | at 2024-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥263.08 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥232.87 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥175.86 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥241.58 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥112.58 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥110 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥110 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥70 | 2022-04-01 → 2023-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥85 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥45 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,800.73 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,658.93 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,484.83 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,385.25 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,192.91 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 77.0% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.8% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.8% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.4% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.9% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 9.6% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.1% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.2% | 2022-04-01 → 2023-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.6% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.2% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 1,393,459 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,393,459 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,393,459 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,393,459 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,393,459 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 123 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 127 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 133 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 133 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 135 | at 2021-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 50
| Segment | Item | Period | Value |
|---|---|---|---|
| Healthcare Related Productsreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥2m |
| Healthcare Related Productsreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥7m |
| Healthcare Related Productsreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥711m |
| Healthcare Related Productsreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥711m |
| Healthcare Related Productsreportable segment | segment assets | at 2025-03-31 | ¥427m |
| Healthcare Related Productsreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥40m |
| Optical Applications And Special Customized Productsreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥487m |
| Optical Applications And Special Customized Productsreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥23m |
| Optical Applications And Special Customized Productsreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥936m |
| Optical Applications And Special Customized Productsreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥936m |
| Optical Applications And Special Customized Productsreportable segment | segment assets | at 2025-03-31 | ¥1.1bn |
| Optical Applications And Special Customized Productsreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥259m |
| X Ray Residual Stress Analyzerreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥28m |
| X Ray Residual Stress Analyzerreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥10m |
| X Ray Residual Stress Analyzerreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥839m |
| X Ray Residual Stress Analyzerreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥839m |
| X Ray Residual Stress Analyzerreportable segment | segment assets | at 2025-03-31 | ¥415m |
| X Ray Residual Stress Analyzerreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥363m |
| —segment total | employees | at 2025-03-31 | 109 pure |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-04-01 → 2025-03-31 | ¥518m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-04-01 → 2025-03-31 | ¥40m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2025-03-31 | ¥2.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2025-03-31 | ¥2.5bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-03-31 | ¥1.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2025-03-31 | ¥662m |
| Healthcare Related Productsreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥2m |
| Healthcare Related Productsreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥8m |
| Healthcare Related Productsreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥901m |
| Healthcare Related Productsreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥901m |
| Healthcare Related Productsreportable segment | segment assets | at 2024-03-31 | ¥471m |
| Healthcare Related Productsreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥43m |
| Optical Applications And Special Customized Productsreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥2m |
| Optical Applications And Special Customized Productsreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥11m |
| Optical Applications And Special Customized Productsreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥819m |
| Optical Applications And Special Customized Productsreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥819m |
| Optical Applications And Special Customized Productsreportable segment | segment assets | at 2024-03-31 | ¥507m |
| Optical Applications And Special Customized Productsreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥259m |
| X Ray Residual Stress Analyzerreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥5m |
| X Ray Residual Stress Analyzerreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥14m |
| X Ray Residual Stress Analyzerreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥891m |
| X Ray Residual Stress Analyzerreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥891m |
| X Ray Residual Stress Analyzerreportable segment | segment assets | at 2024-03-31 | ¥479m |
| X Ray Residual Stress Analyzerreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥384m |
| Total Of Reportable Segments And Otherssegment total | capex | 2023-04-01 → 2024-03-31 | ¥10m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-04-01 → 2024-03-31 | ¥33m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2024-03-31 | ¥2.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2024-03-31 | ¥2.6bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2024-03-31 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2024-03-31 | ¥686m |
| —segment total | employees | at 2025-03-31 | 108 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,242
| Item | Context | Value | Unit |
|---|---|---|---|
| Operating income | CurrentYearDuration_TotalOfReportableSegmentsAndOthersMember | 662080000 | JPY |
| Assets | CurrentYearInstant_jpcrp030000-asr_E02021-000XRayResidualStressAnalyzerReportableSegmentMember | 415295000 | JPY |
| Assets | CurrentYearInstant_jpcrp030000-asr_E02021-000HealthcareRelatedProductsReportableSegmentMember | 427193000 | JPY |
| Assets | CurrentYearInstant_jpcrp030000-asr_E02021-000OpticalApplicationsAndSpecialCustomizedProductsReportableSegmentMember | 1054380000 | JPY |
| Assets | CurrentYearInstant_TotalOfReportableSegmentsAndOthersMember | 1896869000 | JPY |
| Depreciation segment information | CurrentYearDuration_jpcrp030000-asr_E02021-000XRayResidualStressAnalyzerReportableSegmentMember | 9938000 | JPY |
| Depreciation segment information | CurrentYearDuration_jpcrp030000-asr_E02021-000HealthcareRelatedProductsReportableSegmentMember | 6798000 | JPY |
| Depreciation segment information | CurrentYearDuration_jpcrp030000-asr_E02021-000OpticalApplicationsAndSpecialCustomizedProductsReportableSegmentMember | 22858000 | JPY |
| Depreciation segment information | CurrentYearDuration_TotalOfReportableSegmentsAndOthersMember | 39595000 | JPY |
| Increase in property plant and equipment and intangible assets | CurrentYearDuration_jpcrp030000-asr_E02021-000XRayResidualStressAnalyzerReportableSegmentMember | 28123000 | JPY |
| Increase in property plant and equipment and intangible assets | CurrentYearDuration_jpcrp030000-asr_E02021-000HealthcareRelatedProductsReportableSegmentMember | 2257000 | JPY |
| Increase in property plant and equipment and intangible assets | CurrentYearDuration_jpcrp030000-asr_E02021-000OpticalApplicationsAndSpecialCustomizedProductsReportableSegmentMember | 487411000 | JPY |
| Increase in property plant and equipment and intangible assets | CurrentYearDuration_TotalOfReportableSegmentsAndOthersMember | 517792000 | JPY |
| Cash and deposits | Prior1YearInstant_NonConsolidatedMember | 2212691000 | JPY |
| Cash and deposits | CurrentYearInstant_NonConsolidatedMember | 1858175000 | JPY |
| Notes receivable trade | Prior1YearInstant_NonConsolidatedMember | 203164000 | JPY |
| Notes receivable trade | CurrentYearInstant_NonConsolidatedMember | 253473000 | JPY |
| Accounts receivable trade | Prior1YearInstant_NonConsolidatedMember | 735452000 | JPY |
| Accounts receivable trade | CurrentYearInstant_NonConsolidatedMember | 599544000 | JPY |
| Work in process | Prior1YearInstant_NonConsolidatedMember | 447164000 | JPY |
| Work in process | CurrentYearInstant_NonConsolidatedMember | 407103000 | JPY |
| Raw materials and supplies | Prior1YearInstant_NonConsolidatedMember | 451252000 | JPY |
| Raw materials and supplies | CurrentYearInstant_NonConsolidatedMember | 366370000 | JPY |
| Other ca | Prior1YearInstant_NonConsolidatedMember | 38271000 | JPY |
| Other ca | CurrentYearInstant_NonConsolidatedMember | 22125000 | JPY |
| Current assets | Prior1YearInstant_NonConsolidatedMember | 4087996000 | JPY |
| Current assets | CurrentYearInstant_NonConsolidatedMember | 3506793000 | JPY |
| Buildings and structures net | Prior1YearInstant_NonConsolidatedMember | 223993000 | JPY |
| Buildings and structures net | CurrentYearInstant_NonConsolidatedMember | 616543000 | JPY |
| Machinery and equipment net | Prior1YearInstant_NonConsolidatedMember | 47581000 | JPY |
| Machinery and equipment net | CurrentYearInstant_NonConsolidatedMember | 72637000 | JPY |
| Tools furniture and fixtures net | Prior1YearInstant_NonConsolidatedMember | 27221000 | JPY |
| Tools furniture and fixtures net | CurrentYearInstant_NonConsolidatedMember | 39903000 | JPY |
| Land | Prior1YearInstant_NonConsolidatedMember | 196055000 | JPY |
| Land | CurrentYearInstant_NonConsolidatedMember | 196055000 | JPY |
| Construction in progress | Prior1YearInstant_NonConsolidatedMember | 117607000 | JPY |
| Construction in progress | CurrentYearInstant_NonConsolidatedMember | 23983000 | JPY |
| Other net ppe | Prior1YearInstant_NonConsolidatedMember | 0 | JPY |
| Other net ppe | CurrentYearInstant_NonConsolidatedMember | 0 | JPY |
| Property plant and equipment | Prior1YearInstant_NonConsolidatedMember | 612458000 | JPY |
| Property plant and equipment | CurrentYearInstant_NonConsolidatedMember | 949124000 | JPY |
| Intangible assets | Prior1YearInstant_NonConsolidatedMember | 5564000 | JPY |
| Intangible assets | CurrentYearInstant_NonConsolidatedMember | 1533000 | JPY |
| Investment securities | Prior1YearInstant_NonConsolidatedMember | 83743000 | JPY |
| Investment securities | CurrentYearInstant_NonConsolidatedMember | 61913000 | JPY |
| Stocks of subsidiaries and affiliates | Prior1YearInstant_NonConsolidatedMember | 53292000 | JPY |
| Stocks of subsidiaries and affiliates | CurrentYearInstant_NonConsolidatedMember | 53292000 | JPY |
| Long term deposits | Prior1YearInstant_NonConsolidatedMember | 124535000 | JPY |
| Long term deposits | CurrentYearInstant_NonConsolidatedMember | 124535000 | JPY |
| Deferred tax assets | Prior1YearInstant_NonConsolidatedMember | 97217000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |